// App-Quantinova.ai

1496 : Do Patients in MDA Report Low Disease Activity Regardless of Which of the MDA Criteria Are Met?

Researchers

Presenter

  • Laura Coates

Principal Investigators

  • Sarah Yazji

  • Philip Helliwell

  • Andra Balanescu

  • JUAN CANETE

  • Emmanuelle Dernis

  • Uta Kiltz

  • Ying Ying Leung

  • Ennio Lubrano

  • Ana-Maria Orbai

  • PENELOPE PALOMINOS

  • Rossana Scrivo

  • Josef Smolen

  • Sandra Meisalu

  • Maarten de Wit

  • Laure Gossec

Medical Centers

  • University of Oxford, Oxford, United Kingdom

  • University of Medicine and Pharmacy Carol Davila, Bucharest, Romania

  • Hematology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain

  • LE MANS general hospital, LE MANS, France

  • Rheumazentrum Ruhrgebiet, Herne, Germany

  • De- partment of Rheumatology and Immunology, Singapapore General Hospital, Singapore, Singapore

  • 15. Academic Rheumatology Unit, Dipartimento di Medicina e Scienze della Salute ’Vincenzo Tiberio’, University of Molise, Campobasso, Italy

  • Johns Hopkins University School of Medicine, Devision of Rheumatology, Baltimore, MD

  • Hospital De Clinicas de Porto Alegre, Porto Alegre RS, Brazil

  • Rheumatology Unit, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy, Roma, Rome, Italy

  • Medical University of Vienna, Vienna, Austria

  • East Tallinn Central Hospital, Tallinn, Estonia

  • Patient Partner, Amsterdam, Netherlands

  • Sorbonne Universites, Paris, France

  • Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences,, Oxford University Hospitals NHS Trust, Oxford, UK, Oxford, United Kingdom

Locations

  • United Kingdom

  • Romania

  • Spain

  • France

  • Germany

  • Singapore

  • Italy

  • United States

  • Brazil

  • Austria

  • Estonia

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Dermatology

Disease

  • Psoriatic arthritis

Biomarkers

  • Hepatocyte growth factor receptor

  • Malondialdehyde

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cross-Sectional

Phase

  • N/A

Study Id's

  • NCT03119805

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved